Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

  2021 2020 2019 2018 2017 2016

Year wise published articles

50 27 55 66 38 13

Year wise citations received

494 462 352 277 260 226
Journal total citations count 3847
Journal impact factor 12.24
Journal 5 years impact factor 8.50
Journal cite score 10.62
Journal h-index 29
Journal h-index since 2018 21
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • Pelletier JP and Martel-Pelletier J, 2011. The DMOAD dream: a generation later.

    View at Publisher | View at Google Scholar
  • Hadidi E, Mojtahedzadeh M, Paknejad MH, Nikfar S, Zamani MJ,et al. (2006) Alterations of blood IL-8, TGF-β1 and nitric oxide levels in relation to blood cells in patients with acute brain injury.

    View at Publisher | View at Google Scholar
  • Seyedi SY, Salehi F, Payandemehr B, Hossein S, Hosseini‐Zare MS, et al. (2014) Dual effect of cAMP agonist on ameliorative function of PKA inhibitor in morphine‐dependent mice. Fundamental & clinical pharmacology 28:445-454.

    View at Publisher | View at Google Scholar
  • Murad HA, Abdallah HM (2014) Black Tea Extract and its Thearubigins Relieve the Sildenafil‐Induced Delayed Gut Motility in Mice: A Possible Role of Nitric Oxide. Phytotherapy Research 28: 1687-1691.

    View at Publisher | View at Google Scholar
  • Sakhaee E, Emadi L, Azari O, Khanaman FS (2011) Evaluation of the beneficial effects of Zataria multiflora Boiss in halothane-induced hepatotoxicity in rats. Advances in Clinical and Experimental Medicine 20: 23-29.

    View at Publisher | View at Google Scholar
  • KHOWAILED A, MOHAMMAD O, ELATTAR S, GABER S (2012) Effect of sildenafil on gonadotrophin and sex steroids in fructose induced diabetes in female rats. The Medical Journal of Cairo University 80.

    View at Publisher | View at Google Scholar
  • Hajighorbani M, Ahmadi-hamedani M, Shahab E, Hayati F, Kafshdoozan K, et al. (2017) Evaluation of the protective effect of pentoxifylline on carrageenan-induced chronic non-bacterial prostatitis in rats. Inflammopharmacology 9: 1-8.

    View at Publisher | View at Google Scholar
  • Bi-xing Y, Liu-qin J,Lin L (2010) Study on clinical study of gastrointestinal neuroendocrine tumors. Chinese Journal of Digestion 19: 139-141.

    View at Publisher | View at Google Scholar
  • Eberhardt R, Herth FJ (2006) Endosonographie in der Diagnostik und im Staging des Bronchialkarzinoms. Pneumologie 60: 562-567.

    View at Publisher | View at Google Scholar
  • Eberhardt R (2009) Endobronchial Ultrasound for Peripheral Lesions. InEndobronchial Ultrasound.Springer US 103-117.

    View at Publisher | View at Google Scholar
  • Eberhardt R, Bugalho A (2009) Ultrasound Guidance for Endoscopic Treatment of Pulmonary Malignancies. InClinical Chest Ultrasound. Karger Publishers 37: 202-207.

    View at Publisher | View at Google Scholar
  • Dunning BE, Gerich JE (2007) The role of α-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocrine reviews 28: 253-283.

    View at Publisher | View at Google Scholar
  • Ahrén B (2009) Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nature reviews Drug discovery 8: 369-385.

    View at Publisher | View at Google Scholar
  • Ahrén B (2007) Dipeptidyl peptidase-4 inhibitors. Diabetes care 30: 1344-1350.

    View at Publisher | View at Google Scholar
  • Ahren B (2007) DPP-4 inhibitors. Best Practice & Research Clinical Endocrinology & Metabolism 21: 517-533.

    View at Publisher | View at Google Scholar
  • Ahrén B (2009) Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin–diabetes control and potential adverse events. Best Practice & Research Clinical Endocrinology & Metabolism 23: 487-498.

    View at Publisher | View at Google Scholar
  • Ahrén B (2008) Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes. Expert opinion on emerging drugs 13: 593-607.

    View at Publisher | View at Google Scholar
  • Ahrén B (2006) Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties. Expert opinion on investigational drugs 15: 431-442.

    View at Publisher | View at Google Scholar
  • Ahrén B (2011) GLP-1 for type 2 diabetes. Experimental cell research 317: 1239-1245.

    View at Publisher | View at Google Scholar
  • Ahrén B (2010) Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin. Diabetes Metab Syndr Obes 3: 41.

    View at Publisher | View at Google Scholar
  • Ahrén B (2007) GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors. Current diabetes reports 7: 340-347.

    View at Publisher | View at Google Scholar
  • Pratley RE, Salsali A, Matfin G (2006) Review: Inhibition of dipeptidyl peptidase-4 with vildagliptin: a potential new treatment for type 2 diabetes. The British Journal of Diabetes & Vascular Disease 6: 150-156.

    View at Publisher | View at Google Scholar
  • Kalra S (2011) Emerging role of dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin in the management of type 2 diabetes. J Assoc Physicians India 59: 237-245.

    View at Publisher | View at Google Scholar
  • Ahrén B, Burke B (2012) Using albumin to improve the therapeutic properties of diabetes treatments. Diabetes, Obesity and Metabolism 14: 121-129.

    View at Publisher | View at Google Scholar
  • Ahrén Bo (2008) Vildagliptin: novel pharmacological approach to treat type 2 diabetes.79-90. Harvard

    View at Publisher | View at Google Scholar
  • Ahrén B (2011) Inhibition of dipeptidyl peptidase-4 (DPP-4): a target to treat type 2 diabetes. Current Enzyme Inhibition 7: 205-217.

    View at Publisher | View at Google Scholar
  • Ahrén B (2009) DPP-4 inhibitors. Insulin 4: 15-31.

    View at Publisher | View at Google Scholar
  • Ma Y, Liu T, Liu J and Li T, 2011.Progress in Glucagon-like Peptide-1 and Its Analogues. Northwest Medical Journal, 26 (12), pp. 482-484.

    View at Publisher | View at Google Scholar
  • Kupsal K, Mudigonda S, Sai NVBK, Neelala K and Hanumanth SR, 2016. Metformin Combinatorial Therapy for Type 2 Diabetes Mellitus. J Metabolic Synd, 5(210), pp.2167-0943.

    View at Publisher | View at Google Scholar
  • Page RCL, 2008. 42-Insulin, other hypoglycemic drugs, and glucagon. Side Effects of Drugs Annual, 30, pp.494-506.

    View at Publisher | View at Google Scholar
  • Order JAPI, 2011. Sanjay Kalra. Order, 59.

    View at Publisher | View at Google Scholar
  • Pelletier JP, Kapoor M, Fahmi H, Lajeunesse D, Blesius A, et al. 2012. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium. Annals of the rheumatic diseases, pp.annrheumdis-2012. View at Publisher | View at Google Scholar | View at Indexing
  • Pelletier JP, Troncy É, Bertaim T, Thibaud D, Goulet AC, et al. 2011. Treatment with tiludronic acid helps reduce the development of experimental osteoarthritis lesions in dogs with anterior cruciate ligament transection followed by reconstructive surgery: a 1-year study with quantitative magnetic resonance imaging. The Journal of rheumatology, 38(1), pp.118-128. View at Publisher | View at Google Scholar | View at Indexing
  • Moreau M, Pelletier JP, Lussier B, d’Anjou MA, Blond L, et al. 2013. A posteriori comparison of natural and surgical destabilization models of canine osteoarthritis. BioMed research international, 2013. View at Publisher | View at Google Scholar | View at Indexing
  • Gharbi M, Sanchez C, Mazzucchelli G, De Pauw E and Henrotin Y, 2013. Identification of differential pattern of protein expression in canine osteoarthritis serum after anterior cruciate ligament transection: a proteomic analysis. The Veterinary Journal, 197(3), pp.848-853. View at Publisher | View at Google Scholar | View at Indexing
  • Jotanovic Z, Mihelic R, Sestan B and Dembic Z, 2014. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment. Current drug targets, 15(6), pp.635-661. View at Publisher | View at Google Scholar | View at Indexing
  • Kuyinu EL, Narayanan G, Nair LS and Laurencin CT, 2016. Animal models of osteoarthritis: classification, update, and measurement of outcomes. Journal of orthopaedic surgery and research, 11(1), p.19. View at Publisher | View at Google Scholar | View at Indexing
  • Pelletier JP, Martel-Pelletier J and Reginster JY, 2010. Osteoarthritis in 2010. Therapy, 7(6), pp.575-577. View at Publisher | View at Google Scholar | View at Indexing
  • Pelletier JP, Martel-Pelletier J and Reginster JY, 2010. Osteoarthritis in 2010. Therapy, 7(6), pp.575-577. View at Publisher | View at Google Scholar | View at Indexing
  • Ringe JD, Body JJ (2007) A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover. Clinical and experimental rheumatology 25: 766.

    View at Publisher | View at Google Scholar
  • Epstein S, Delmas PD, Emkey R, Wilson KM, Hiltbrunner V, et al. (2006) Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety. Maturitas 54: 1-0.

    View at Publisher | View at Google Scholar
  • Cohen J, Douma WR, ten Hacken NH, Vonk JM, Oudkerk M, et al. (2008) Ciclesonide improves measures of small airway involvement in asthma. European Respiratory Journal 31: 1213-1220.

    View at Publisher | View at Google Scholar
  • Canonica GW, Baena‐Cagnani CE, Blaiss MS, Dahl R, Kaliner MA,et al. (2007) Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy 62: 668-674.

    View at Publisher | View at Google Scholar
  • Cohen J, Postma DS, Douma WR, Vonk JM, De Boer AH, et al. (2011) Particle size matters: diagnostics and treatment of small airways involvement in asthma. European Respiratory Journal 37: 532-540.

    View at Publisher | View at Google Scholar
  • Brand PL, García-García ML, Morison A, Vermeulen JH, Weber HC (2011) Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory medicine 105: 1588-1595.

    View at Publisher | View at Google Scholar
  • Colice GL (2006) The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma. Expert opinion on pharmacotherapy 7: 2107-2117.

    View at Publisher | View at Google Scholar
  • Cazzola M, Rogliani P, Novelli L, Matera MG (2013) Inhaled corticosteroids for chronic obstructive pulmonary disease. Expert opinion on pharmacotherapy 14: 2489-2499.

    View at Publisher | View at Google Scholar
  • McDonald Heiner M (2007) Key barriers to optimal management of adult asthma in Australia: physician and patient perspectives. Current medical research and opinion 23: 1799-1807.

    View at Publisher | View at Google Scholar
  • Nathan RA, Kanter L, Ostrom NK (2008) Ciclesonide improves health-related quality of life in adults and adolescents with mild-to-moderate persistent asthma. InAllergy and Asthma Proceedings 29 : 521-527

    View at Publisher | View at Google Scholar
  • Kenreigh CA, Wagner LT, Chrisp P (2006) Ciclesonide in persistent asthma: the evidence of its therapeutic value. Core evidence 1: 233.

    View at Publisher | View at Google Scholar

Relevant Topics

Awards Nomination

Select your language of interest to view the total content in your interested language

Journal Metrics:

Impact Factor: 12.24
Journal Citescore: 10.62
h-index: 29
PubMed NLM ID:  101579384
Journal Acceptance Rate: 40%
Article processing time : 30-45 Days

Google Scholar citation report
Citations : 3847

Clinical Practice received 3847 citations as per Google Scholar report


Clinical Practice peer review process verified at publons

Indexed In

flyer
flyer